Scherm­afbeelding 2024 11 07 om 13.58.58

PITTCON | UNLOCKING INNOVATION TOGETHER:

ADVANCING POINT OF CARE TESTING

Scherm­afbeelding 2024 11 07 om 13.54.17

DIASYS | Respons A1C

One step HbA1c analyzer

Scherm­afbeelding 2024 11 07 om 13.49.31

United expertise for your allergy diagnostics | EUROIMMUN

Let’s embark on a new journey together!

Scherm­afbeelding 2024 11 07 om 13.42.48

New Generation Hospital Glucose/Ketone Meter

Only glucose meter FDA-cleared for use with critically ill patients

drug screening

New single-molecule tracking system accelerates drug discovery process

A new automated screening technology developed by Japanese researchers enables rapid identification of drug candidates by tracking molecular behaviour within cells, offering significant implications for therapeutic development.

cancer drugs 2

Novel drug screening method enhances personalised cancer treatment approach

Finnish researchers have developed a high-throughput screening pipeline that enables simultaneous analysis of multiple drug responses in primary tumour samples at single-cell resolution, offering new possibilities for personalised cancer therapy.

chemical ChatGPT

AI model develops dual-target drug candidates using chemical language processing

Researchers at the University of Bonn have developed an artificial intelligence system that can predict chemical structures of compounds capable of binding to multiple protein targets, potentially streamlining the discovery of more effective therapeutic agents.

Linkoping alphafold

Enhanced AlphaFold capabilities enable large protein structure analysis

Researchers at Linköping University have developed an improved version of the AI protein structure prediction tool AlphaFold, enabling analysis of larger protein complexes and integration of experimental data. The advancement marks a significant step forward in protein research and drug development.

asynt 11

Asynt introduces new tools to expand options for photochemical synthesis

Laboratory equipment manufacturer Asynt has introduced an expanded portfolio of photochemistry reactors, offering researchers enhanced capabilities for both batch and continuous flow applications. This development addresses the growing interest in photochemistry as a ‘reagentless’ activation method in synthetic chemistry.

Sapio Sciences Kevin Cramer

Sapio Sciences expands immunogenicity testing capabilities in laboratory informatics platform

Laboratory software provider Sapio Sciences has announced new immunogenicity bioanalysis features within its laboratory informatics platform, specifically enhancing its Laboratory Information Management System (LIMS) and Electronic Laboratory Notebook (ELN) solutions.